Department of General, Thoracic and Fetal Surgery, Center for Fetal Diagnosis and Therapy, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Philadelphia, PA, USA.
Department of General, Thoracic and Fetal Surgery, Center for Fetal Diagnosis and Therapy, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Philadelphia, PA, USA.
Semin Fetal Neonatal Med. 2017 Dec;22(6):423-427. doi: 10.1016/j.siny.2017.05.002. Epub 2017 May 24.
The field of maternal-fetal intervention is rapidly evolving with new technologies and innovations. This raises complex ethical and medico-legal challenges related to what constitutes innovative treatment versus human experimentation, with or without the umbrella of "medical research." There exists a gray zone between these black and white classifications, but there are also clear guidelines that should be responsibly negotiated when making the essential transition between an innovative treatment and a validated therapy. This review attempts to define some of the current and future ethical challenges in maternal-fetal research, and to offer constructive insight into how they might be addressed.
胎儿医学干预领域正在随着新技术和创新的出现而迅速发展。这带来了与创新治疗与人体实验之间的关系相关的复杂伦理和医学法律挑战,无论是否有“医学研究”的保护伞。在这些黑白分类之间存在一个灰色地带,但在创新治疗与已验证疗法之间进行必要的过渡时,也有明确的指导方针需要负责任地协商。本综述试图定义当前和未来的胎儿医学研究中的一些伦理挑战,并为如何解决这些问题提供建设性的见解。